Background
Dry Eye Disease
Our Solution
Leadership Team
Contact Us
Menu
Background
Dry Eye Disease
Our Solution
Leadership Team
Contact Us
Facebook
Twitter
Linkedin
Press Releases
TearSolutions, Inc. Appoints Leonard Borrmann To Its Board of Directors
View More
Middleland Capital’s VTC Innovation Fundand Pharmstandard International Co-lead $8.5m Series B Financing ofTearSolutions, Inc.
View More
TearSolutions, Inc. Announces Resultsfrom Phase I/II trial of LacripepTMto Treat Primary Sjögren’sSyndrome and Appoints Anil Asrani President and CEO
View More
TearSolutions Raises $3M Series A Round to Advance The Treatment of Dry Eye
View More